| Followers | 368 |
| Posts | 15965 |
| Boards Moderated | 2 |
| Alias Born | 03/15/2017 |
Tuesday, October 05, 2021 7:07:45 AM
I bought some yesterday at close (26) hopefully I didn’t buy too high I never really buy while it’s up that much
Recent XENE News
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 04/13/2026 08:04:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/13/2026 08:01:17 PM
- Xenon to Highlight Phase 3 X-TOLE2 & Long-Term Data for Azetukalner in Focal Onset Seizures at 2026 AAN Annual Meeting • GlobeNewswire Inc. • 04/07/2026 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/14/2026 12:16:56 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/14/2026 12:16:43 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/14/2026 12:16:26 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/13/2026 11:51:04 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/13/2026 11:50:18 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/13/2026 11:49:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/13/2026 08:10:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/12/2026 08:17:51 PM
- Xenon Pharmaceuticals Announces Closing of $747.5 Million Upsized Public Offering Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares • GlobeNewswire Inc. • 03/12/2026 08:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/11/2026 11:21:20 PM
- Xenon Pharmaceuticals Announces Pricing of Upsized $650.0 Million Public Offering • GlobeNewswire Inc. • 03/11/2026 02:39:32 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/11/2026 01:01:40 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 03/09/2026 08:54:06 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/09/2026 08:46:22 PM
- Xenon Pharmaceuticals Announces Proposed Public Offering • GlobeNewswire Inc. • 03/09/2026 08:01:00 PM
- Xenon Pharmaceuticals shares jump 40% after strong Phase 3 seizure trial results • IH Market News • 03/09/2026 02:16:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/09/2026 11:36:58 AM
- Xenon Announces Positive Topline Data from Phase 3 X-TOLE2 Study of Azetukalner in Focal Onset Seizures (FOS) • GlobeNewswire Inc. • 03/09/2026 11:00:00 AM
- Xenon to Announce Topline Results from Phase 3 X-TOLE2 Study of Azetukalner in Focal Onset Seizures on Monday, March 9, 2026 • GlobeNewswire Inc. • 03/08/2026 06:00:00 PM
